Linden Thomas Advisory Services’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
AIM
EB
CPC
AIM
AAMU
AAIS
BCAM
Linden Thomas Advisory Services's DGX Position: Q2 2026 in Review
Linden Thomas Advisory Services increased its Quest Diagnostics (DGX) stake by 2.7% in Q2 2026, buying an estimated $64.6K and bringing the position to 12,539 shares worth $2.66M. The position accounts for 0.21% of the portfolio, ranked #141.
Linden Thomas Advisory Services first reported a position in DGX in Q4 2022 and has held it in 15 quarters since. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Linden Thomas Advisory Services held 12,539 shares of Quest Diagnostics worth $2.66M as of Q2 2026.
- Linden Thomas Advisory Services bought 329 Quest Diagnostics shares in Q2 2026, an estimated $64.6K.
- Quest Diagnostics made up 0.21% of Linden Thomas Advisory Services's portfolio in Q2 2026, its #141 holding.
- Linden Thomas Advisory Services first reported a position in Quest Diagnostics in Q4 2022 and has held it in 15 quarters since.
- 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Linden Thomas Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.